Scios, Inc.

Quick facts

Marketed products

• nesiritide, furosemide · Cardiovascular
  Nesiritide is a recombinant B-type natriuretic peptide that promotes vasodilation and sodium excretion, while furosemide is a loop diuretic that inhibits sodium and chloride reabsorption in the ascending loop of Henle.

Phase 3 pipeline

• Natrecor (nesiritide) · Cardiovascular
  Nesiritide is a recombinant B-type natriuretic peptide that binds to natriuretic peptide receptors to promote vasodilation, reduce cardiac preload and afterload, and increase sodium excretion.
• usual long term cardiac medications

Phase 2 pipeline

• SCIO-469
• SCIO-469 and bortezomib

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Scios, Inc. portfolio CI brief
• Scios, Inc. pipeline updates RSS